Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.
Zenocutuzumab 是一种 HER2xHER3 双特异性抗体，可有效治疗由 NRG1 基因重排驱动的肿瘤
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-21-1119
Schram Alison M, Odintsov Igor, Espinosa-Cotton Madelyn, Khodos Inna, Sisso Whitney J, Mattar Marissa S, Lui Allan J W, Vojnic Morana, Shameem Sara H, Chauhan Thrusha, Torrisi Jean, Ford Jim, O'Connor Marie N, Geuijen Cecile A W, Schackmann Ron C J, Lammerts van Bueren Jeroen J, Wasserman Ernesto, de Stanchina Elisa, O'Reilly Eileen M, Ladanyi Marc, Drilon Alexander, Somwar Romel
